Furthermore, the high expression of CD133 is correlated with the increased tumor grade, advanced disease stage, elevated serum alpha-fetoprotein levels and poor survival of the patients with hepatocellular carcinoma [21]. This evidence concerns the gene PROM1 and neoplasm.